Results 151 to 160 of about 1,301,860 (307)

Acute Respiratory Failure as the First Sign of Non-Fibrotic Hypersensitivity Pneumonitis – Diagnostic and Therapeutic Challenges

Katarzyna Lewandowska, Lucyna Opoka, Iwona Bartoszuk, Małgorzata Ewa Jędrych, Piotr Radwan-Röhrenschef, Kamila Deutsch, Adriana Roży, Lilia Jakubowska, Witold Tomkowski, Małgorzata Sobiecka, Monika Szturmowicz   +10 more
openalex   +1 more source

Lower Respiratory Tract Hypersensitivity in Allergic Rhinitis and Perennial Nonallergic Rhinitis.

, 1996
Nobuo Usui, Michihiro Watanabe, T Yuasa, Akio Iwata, Yoshio Takagi, Katsuya Harada   +5 more
openalex   +2 more sources

The Body Habitus Factor in the Seasonal Distributions of Common Respiratory Infections among Hypersensitive Young Men [PDF]

, 1940
Frederick Sargent
openalex   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta, Tong Wang, Susmita, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +5 more
wiley   +1 more source

Diagnosis and Treatment of Hypersensitivity Pneumonitis: S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology [PDF]

D. Koschel, Jürgen Behr, Markus Berger, Francesco Bonella, Okka W. Hamer, Marcus Joest, Danny Jonigk, Michael Kreuter, Gabriela Leuschner, Dennis Nowak, Monika Raulf, B. Rehbock, Jens Schreiber, H. Sitter, Dirk Theegarten, Ulrich Costabel   +15 more
openalex   +1 more source

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami, Yukari Okubo, Satomi Kobayashi, Natsuko Kikuta, Yoshiumi Ouchi, Kenta Shishido, Tadashi Terui   +6 more
wiley   +1 more source

Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Cannabis use is rising among adults, yet few users receive structured medical supervision. Older users face unique risks necessitating specialized oversight. Given their longitudinal relationships and detailed understanding of patients' health and goals, primary care providers are well‐positioned to guide decisions and education ...
Ryan Weaver, Brian Velez, Michael L. Weissberger, Kristin M. Zimmerman   +3 more
wiley   +1 more source

Perinatal Risk Factors and Clinical Correlations in Molar-Incisor Hypomineralization: A Cross-Sectional Epidemiological Study. [PDF]

Epidemiologia (Basel)
Kis EÉ, Gecse IB, Bica C, Dudás C, Dudás H, Martha K.   +5 more
europepmc   +1 more source

Full‐Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) Improves Symptoms of Rett Syndrome: An Open‐Label Study

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim The aim of this Phase I/II open‐label study was to assess the safety and efficacy of NTI164, a novel full‐spectrum medicinal cannabis plant extract 0.08% Δ‐9‐tetrahydrocannabinol (THC), in Rett syndrome (RTT). Methods Eleven female participants (5–16 years) with a pathogenic variant in the MECP2 gene were recruited to this study, receiving
B. A. Keating, Y. Ogru, T. G. Duthy, L. Douglas, K. Lichkus, E. Isikgel, M. C. Fahey, C. Ellaway   +7 more
wiley   +1 more source

Inflammatory and Immunological Basis of Periodontal Diseases

Journal of Periodontal Research, EarlyView.
The periodontal lesion emerges as an evolving immunological battlefield, where host–microbiome interactions, dysregulated immune responses, fragile resolution mechanisms, and inflammophilic dysbiosis converge to shift the balance from homeostasis to unrestrained tissue destruction.
Giacomo Baima, Marion Arce, Mario Romandini, Thomas Van Dyke   +3 more
wiley   +1 more source